Intensity Therapeutics, Inc.
INTS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001567264
No open-market purchases or sales by Intensity Therapeutics, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $4.79M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Intensity Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +6 vs. Q1 2025
- Shares held
- 1.98M
- −609.8K (−23.6%) vs. Q1 2025
- Total value
- $606.6K
- −$4.49M (−88.1%) vs. Q1 2025
- New holders
- 10
- 7 more added
- Sold out
- 4
- 2 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INTS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $4.79M |
| Q1 2026 | 14 | $1.06M |
| Q4 2025 | 35 | $1.58M |
| Q3 2025 | 26 | $721.2K |
| Q2 2025 | 27 | $606.6K |
| Q1 2025 | 21 | $5.10M |
| Q4 2024 | 20 | $4.79M |
| Q3 2024 | 20 | $6.65M |
| Q2 2024 | 23 | $8.23M |
| Q1 2024 | 18 | $8.49M |
| Q4 2023 | 17 | $4.39M |
| Q3 2023 | 10 | $1.19M |
| Q2 2023 | 2 | $170.2K |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Intensity Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 100 | $31 | 0.00% | +100 | New |
| Bank of America Corp | 388 | $119 | 0.00% | +325+515.9% | Added |
| Morgan Stanley | 500 | $154 | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 5,000 | $1.53K | 0.00% | +5,000 | New |
| UBS Group AG | 9,234 | $2.83K | 0.00% | +6,137+198.2% | Added |
| Cubist Systematic Strategies, LLC | 11,673 | $3.58K | 0.00% | +11,673 | New |
| Virtu Financial LLC | 13,700 | $4.00K | 0.00% | +13,700 | New |
| Tower Research Capital LLC (TRC) | 13,491 | $4.14K | 0.00% | +11,115+467.8% | Added |
| Northern Trust Corp | 14,024 | $4.30K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 14,500 | $4.45K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 15,000 | $4.61K | 0.00% | +15,000 | New |
| Ewa, LLC | 16,032 | $4.92K | 0.00% | +16,032 | New |
| Stonebridge Financial Group, LLC | 16,525 | $5.07K | 0.00% | +7,000+73.5% | Added |
| QTR Family Wealth, LLC | 17,420 | $5.35K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 24,904 | $7.00K | 0.00% | +24,904 | New |
| XTX Topco Ltd | 24,553 | $7.54K | 0.00% | +24,553 | New |
| One Charles Private Wealth Services, LLC | 31,800 | $9.76K | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 37,805 | $11.6K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 40,587 | $12.5K | 0.00% | −190,072−82.4% | Reduced |
| Jane Street Group, LLC | 44,897 | $13.8K | 0.00% | +44,897 | New |
| Warberg Asset Management LLC | 68,400 | $21.0K | 0.01% | +68,400 | New |
| Sigma Planning Corp | 69,167 | $21.2K | 0.00% | +14,330+26.1% | Added |
| Geode Capital Management, LLC | 72,813 | $22.4K | 0.00% | −4,669−6.0% | Reduced |
| Mesirow Financial Investment Management, Inc. | 110,000 | $33.8K | 0.00% | +70,000+175.0% | Added |
| Brown Advisory Inc | 130,072 | $39.9K | 0.00% | 00.0% | Unchanged |
| Sentinus, LLC | 199,316 | $61.2K | 0.02% | +172,012+630.0% | Added |
| Sapient Capital LLC | 976,797 | $299.9K | 0.01% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −872,547−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −25,801−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −21,835−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −15−100.0% | Sold out |